Immunomodulatory analogs of thalidomide: an emerging new therapy in myeloma
- PMID: 15249587
- DOI: 10.1200/JCO.2004.05.984
Immunomodulatory analogs of thalidomide: an emerging new therapy in myeloma
Comment on
-
Phase I study of an immunomodulatory thalidomide analog, CC-4047, in relapsed or refractory multiple myeloma.J Clin Oncol. 2004 Aug 15;22(16):3269-76. doi: 10.1200/JCO.2004.10.052. Epub 2004 Jul 12. J Clin Oncol. 2004. PMID: 15249589 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical